Home › Funds › Bellevue Group AG › AVLN

Bellevue Group AG position in AVLN

AVALYN PHARMA INC · Health Care

Bellevue Group AG reported holding 1,350,000 shares of AVLN (AVALYN PHARMA INC) in its Q2 2026 13F filing — a position valued at US$44.4M, representing 0.94% of its reported portfolio and ranking #31 among its reported holdings. Bellevue Group AG first reported this position in Q2 2026.

Latest position (Q2 2026)1.35M sh
Reported value held$44.44M
Portfolio Weight0.94%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Bellevue Group AG's AVLN position evolved

Bellevue Group AG first disclosed a stake in AVLN in Q2 2026 at 1,350,000 shares (US$44.4M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 1.35M $44.44M New

About AVLN and 13F data

AVLN (AVALYN PHARMA INC) is a Health Care company. 97 other funds we track also report a position in AVLN — the largest reported positions include Novo Holdings A/S (US$127.8M), SR ONE CAPITAL MANAGEMENT, LP (US$108.9M), PERCEPTIVE ADVISORS LLC (US$88.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AVLN

All AVLN fund holders →

FAQ

How long has Bellevue Group AG held AVLN?

Bellevue Group AG has disclosed AVLN holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Bellevue Group AG's current position in AVLN?

As of Q2 2026, Bellevue Group AG holds 1.35M shares of AVLN (AVALYN PHARMA INC), valued at $44.44M, representing 0.94% of its reported portfolio and ranking #31.

Has Bellevue Group AG been buying or selling AVLN?

In the latest 13F filing (Q2 2026), Bellevue Group AG newly opened its position in AVLN.

Which other funds hold AVLN?

Other major institutional holders of AVLN include Novo Holdings A/S, SR ONE CAPITAL MANAGEMENT, LP, PERCEPTIVE ADVISORS LLC, among 97 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.